Earnings Previews: Abbott Labs, ASML, Baker Hughes, Procter & Gamble

Among 23 analysts covering Abbott Labs stock, 17 have a Buy or Strong Buy rating, and four more rate the shares at Hold. The median price target is $125.00, and with shares trading at around $100.90, the upside potential is 23.9%. At the high target of $145.00, the upside potential increases to 43.7%.

Third-quarter revenue is forecast to drop sequentially by about 14.3% to $9.65 billion and to decrease by about 11.7% year over year. Adjusted EPS are forecast at $0.94, down by about 34% sequentially and by 32.9% year over year. For the full 2022 fiscal year, analysts are looking for adjusted EPS of $5.05, down about 3.1%, on revenue of $42.54 billion, down 1.3%.

Abbott Labs stock trades 20.0 times expected 2022 EPS, 21.7 times estimated 2023 earnings of $4.65 and 19.7 times estimated 2024 earnings of $5.12 per share. The stock’s 52-week trading range is $96.67 to $142.60, and the company pays an annual dividend of $1.88 (yield of 1.86%). Total shareholder return for the past 12 months was negative 12.7%.

ASML

Semiconductor manufacturing equipment maker ASML Holding N.V. (NASDAQ: ASML) stock has plunged by more than 50% over the past 12 months, including a slide of 6.5% last Friday. The U.S. ban on exporting advanced chip and chipmaking technology to China has driven the sector’s average share price loss to almost 33% over the past year. For the year to date, the sector has declined by 47%, and ASML has dropped 50%.

Of 32 analysts following the stock, 25 have a Buy or Strong Buy rating and six have Hold ratings. At a share price of around $395.90, the implied upside based on a median price target of about $624.00 is 57.2%. At the high price target of $896.95, the upside potential reaches 126%.

Analysts expect the company to report revenue of $5.29 billion for the September quarter, down by about 9.3% sequentially and 12.9% lower year over year. Adjusted EPS are forecast at $3.36, down 7.1% sequentially and by 31.8% year over year. For the full 2022 fiscal year, analysts anticipate EPS of $13.01, down by about 17.7% year over year, on revenue of $20.19 billion, down 4.7%.

ASML stock trades at around 31.1 times expected 2022 EPS, 21.9 times estimated 2023 EPS of $18.46 and 18.7 times estimated 2024 earnings of $21.67 per share. The stock’s 52-week range is $363.15 to $881.12. The low was posted last week. The company pays an annual dividend of $5.29 per share (yield of 1.4%). Total shareholder return for the past 12 months was negative 49.2%.

Baker Hughes

For every 10 sectors trading lower in the past year, there is one trading higher. That would be energy, which has added almost 45% to its sector average this year. Oilfield services firm Baker Hughes Co. (NASDAQ: BKR) is not doing its part. The stock has dropped about 11.5% of its value over the past 12 months, after touching a new 52-week low late last month.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.